The Mild Cognitive Impairment Therapeutic Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Mild Cognitive Impairment Therapeutic Market. With the use of historic data from (period), the Mild Cognitive Impairment Therapeutic Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report makes it an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders that are in search of major industry information in ready-to-access documents with clearly presented tables and graphs.
The global market for Mild Cognitive Impairment Therapeutic Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The key manufacturers in this market include
On the basis of region, the market is divided into:
By the product type, the market is primarily segmented into
By the End-user Applications, the market is primarily segmented into
We can also provide the customized separate regional or country-level reports, for the following regions:
Key Highlights of the Report:
The report offers you perceptive data of the market and highlights its commercial landscape and pivotal factors that propel and hinder the market growth. It also evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D and focuses on major growth strategies adopted by leading market players. The report accurately projects the global market value and regional share during the forecast period
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Available Customizations
At Worldwide Market Reports we offer tailored researches to help our clients stay ahead in competition.
Table of Contents Mild Cognitive Impairment Therapeutic Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Mild Cognitive Impairment Therapeutic 1.1 Mild Cognitive Impairment Therapeutic Market Overview 1.1.1 Mild Cognitive Impairment Therapeutic Product Scope 1.1.2 Market Status and Outlook 1.2 Global Mild Cognitive Impairment Therapeutic Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Mild Cognitive Impairment Therapeutic Market by Type 1.3.1 Global Mild Cognitive Impairment Therapeutic Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Mild Cognitive Impairment Therapeutic Revenue Market Share by Type in 2018 1.3.3 BAN-2401 1.3.4 Bosutinib 1.3.5 Brexanolone 1.3.6 CSP-1103 1.3.7 Others 1.4 Mild Cognitive Impairment Therapeutic Market by End Users/Application 1.4.1 Hospital 1.4.2 Clinic 1.4.3 Others 2 Global Mild Cognitive Impairment Therapeutic Competition Analysis by Players 2.1 Global Mild Cognitive Impairment Therapeutic Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 AgeneBio Inc 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Avraham Pharmaceuticals Ltd 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 CereSpir Inc 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 ConSynance Therapeutics Inc 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Eisai Co Ltd 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Eli Lilly and Company 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Ensol Biosciences Inc 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Genzyme Corp 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 IntelGenx Corp 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Krenitsky Pharmaceuticals Inc 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Mild Cognitive Impairment Therapeutic Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 Merck & Co Inc 3.12 Nanotherapeutics Inc 3.13 Neuron Biopharma SA 3.14 Pfizer Inc 3.15 Sage Therapeutics Inc 3.16 SBI Pharmaceuticals Co Ltd 3.17 Suven Life Sciences Ltd 3.18 Takeda Pharmaceutical Company Ltd 3.19 Therapix Biosciences Ltd 4 Global Mild Cognitive Impairment Therapeutic Market Size by Type and Application (2014-2019) 4.1 Global Mild Cognitive Impairment Therapeutic Market Size by Type (2014-2019) 4.2 Global Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 4.3 Potential Application of Mild Cognitive Impairment Therapeutic in Future 4.4 Top Consumer/End Users of Mild Cognitive Impairment Therapeutic 5 North America Mild Cognitive Impairment Therapeutic Development Status and Outlook 5.1 North America Mild Cognitive Impairment Therapeutic Market Size (2014-2019) 5.2 North America Mild Cognitive Impairment Therapeutic Market Size and Market Share by Players (2014-2019) 5.3 North America Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 6 Europe Mild Cognitive Impairment Therapeutic Development Status and Outlook 6.1 Europe Mild Cognitive Impairment Therapeutic Market Size (2014-2019) 6.2 Europe Mild Cognitive Impairment Therapeutic Market Size and Market Share by Players (2014-2019) 6.3 Europe Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 7 China Mild Cognitive Impairment Therapeutic Development Status and Outlook 7.1 China Mild Cognitive Impairment Therapeutic Market Size (2014-2019) 7.2 China Mild Cognitive Impairment Therapeutic Market Size and Market Share by Players (2014-2019) 7.3 China Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 8 Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Development Status and Outlook 8.1 Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size (2014-2019) 8.2 Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 9 Central & South America Mild Cognitive Impairment Therapeutic Development Status and Outlook 9.1 Central & South America Mild Cognitive Impairment Therapeutic Market Size (2014-2019) 9.2 Central & South America Mild Cognitive Impairment Therapeutic Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 10 Middle East & Africa Mild Cognitive Impairment Therapeutic Development Status and Outlook 10.1 Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size (2014-2019) 10.2 Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Mild Cognitive Impairment Therapeutic Market Size by Regions (2019-2025) 11.1.1 North America Mild Cognitive Impairment Therapeutic Revenue and Growth Rate (2019-2025) 11.1.2 Europe Mild Cognitive Impairment Therapeutic Revenue and Growth Rate (2019-2025) 11.1.3 China Mild Cognitive Impairment Therapeutic Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Mild Cognitive Impairment Therapeutic Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Mild Cognitive Impairment Therapeutic Revenue and Growth Rate (2019-2025) 11.2 Global Mild Cognitive Impairment Therapeutic Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Mild Cognitive Impairment Therapeutic Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porters Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List List of Table List of Tables and Figures Figure Global Mild Cognitive Impairment Therapeutic Market Size (Million USD) Status and Outlook (2014-2025) Table Global Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Mild Cognitive Impairment Therapeutic Market Share by Regions (2014-2019) Figure North America Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate (2014-2019) Figure China Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Mild Cognitive Impairment Therapeutic Market Share by Type in 2018 & 2025 Figure BAN-2401 Market Size (Million USD) and Growth Rate (2014-2019) Figure Bosutinib Market Size (Million USD) and Growth Rate (2014-2019) Figure Brexanolone Market Size (Million USD) and Growth Rate (2014-2019) Figure CSP-1103 Market Size (Million USD) and Growth Rate (2014-2019) Figure Others Market Size (Million USD) and Growth Rate (2014-2019) Table Global Mild Cognitive Impairment Therapeutic Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Mild Cognitive Impairment Therapeutic Market Share by Application in 2018 & 2025 Figure Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate in Hospital (2014-2019) Figure Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate in Clinic (2014-2019) Figure Mild Cognitive Impairment Therapeutic Market Size (Million USD) and Growth Rate in Others (2014-2019) Table Global Mild Cognitive Impairment Therapeutic Revenue (Million US$) by Players (2014-2019) Table Global Mild Cognitive Impairment Therapeutic Revenue Market Share by Players (2014-2019) Eigure Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table Global Mild Cognitive Impairment Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Mild Cognitive Impairment Therapeutic Market Share in 2018 Figure Global Top 10 Players Mild Cognitive Impairment Therapeutic Market Share in 2018 Table Mild Cognitive Impairment Therapeutic Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table AgeneBio Inc Basic Information List Table AgeneBio Inc Description and Business Overview Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of AgeneBio Inc (2014-2019) Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Recent Developments Table Avraham Pharmaceuticals Ltd Basic Information List Table Avraham Pharmaceuticals Ltd Description and Business Overview Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of Avraham Pharmaceuticals Ltd (2014-2019) Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Recent Developments Table CereSpir Inc Basic Information List Table CereSpir Inc Description and Business Overview Table CereSpir Inc Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of CereSpir Inc (2014-2019) Table CereSpir Inc Mild Cognitive Impairment Therapeutic Recent Developments Table ConSynance Therapeutics Inc Basic Information List Table ConSynance Therapeutics Inc Description and Business Overview Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of ConSynance Therapeutics Inc (2014-2019) Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Recent Developments Table Eisai Co Ltd Basic Information List Table Eisai Co Ltd Description and Business Overview Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of Eisai Co Ltd (2014-2019) Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Recent Developments Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Description and Business Overview Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of Eli Lilly and Company (2014-2019) Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Recent Developments Table Ensol Biosciences Inc Basic Information List Table Ensol Biosciences Inc Description and Business Overview Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of Ensol Biosciences Inc (2014-2019) Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Recent Developments Table Genzyme Corp Basic Information List Table Genzyme Corp Description and Business Overview Table Genzyme Corp Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of Genzyme Corp (2014-2019) Table Genzyme Corp Mild Cognitive Impairment Therapeutic Recent Developments Table IntelGenx Corp Basic Information List Table IntelGenx Corp Description and Business Overview Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of IntelGenx Corp (2014-2019) Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Recent Developments Table Krenitsky Pharmaceuticals Inc Basic Information List Table Krenitsky Pharmaceuticals Inc Description and Business Overview Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Products, Services and Solutions Table Revenue (Million US$) in Mild Cognitive Impairment Therapeutic Business of Krenitsky Pharmaceuticals Inc (2014-2019) Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Recent Developments Table Merck & Co Inc Basic Information List Table Nanotherapeutics Inc Basic Information List Table Neuron Biopharma SA Basic Information List Table Pfizer Inc Basic Information List Table Sage Therapeutics Inc Basic Information List Table SBI Pharmaceuticals Co Ltd Basic Information List Table Suven Life Sciences Ltd Basic Information List Table Takeda Pharmaceutical Company Ltd Basic Information List Table Therapix Biosciences Ltd Basic Information List Table Global Mild Cognitive Impairment Therapeutic Market Size by Type (2014-2019) (Million US$) Figure Global Mild Cognitive Impairment Therapeutic Revenue Market Share by Type in 2018 Table Global Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure Global Mild Cognitive Impairment Therapeutic Revenue Market by Application in 2018 Table Top Consumer/End Users of Mild Cognitive Impairment Therapeutic Figure North America Mild Cognitive Impairment Therapeutic Market Size and Growth Rate(2014-2019) (Million USD) Table North America Mild Cognitive Impairment Therapeutic Market Size by Players (2014-2019)(Million US$) Figure North America Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table North America Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure North America Mild Cognitive Impairment Therapeutic Revenue Market Share by Application (2014-2019) Figure North America Mild Cognitive Impairment Therapeutic Market Size Share by Application in 2018 Figure Europe Mild Cognitive Impairment Therapeutic Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Mild Cognitive Impairment Therapeutic Market Size by Players (2014-2019)(Million US$) Figure Europe Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table Europe Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure Europe Mild Cognitive Impairment Therapeutic Revenue Market Share by Application (2014-2019) Figure Europe Mild Cognitive Impairment Therapeutic Market Size Share by Application in 2018 Figure China Mild Cognitive Impairment Therapeutic Market Size and Growth Rate(2014-2019) (Million USD) Table China Mild Cognitive Impairment Therapeutic Market Size by Players (2014-2019)(Million US$) Figure China Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table China Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure China Mild Cognitive Impairment Therapeutic Revenue Market Share by Application (2014-2019) Figure China Mild Cognitive Impairment Therapeutic Market Size Share by Application in 2018 Figure Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Market Size Share by Application in 2018 Figure Central & South America Mild Cognitive Impairment Therapeutic Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Mild Cognitive Impairment Therapeutic Market Size by Players (2014-2019)(Million US$) Figure Central & South America Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table Central & South America Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure Central & South America Mild Cognitive Impairment Therapeutic Revenue Market Share by Application (2014-2019) Figure Central & South America Mild Cognitive Impairment Therapeutic Market Size Share by Application in 2018 Figure Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size Share by Players in 2018 Table Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Mild Cognitive Impairment Therapeutic Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Mild Cognitive Impairment Therapeutic Market Size Share by Application in 2018 Figure Global Mild Cognitive Impairment Therapeutic Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Mild Cognitive Impairment Therapeutic Market Size by Regions (2019-2025) (Million US$) Figure Global Mild Cognitive Impairment Therapeutic Market Size Share by Regions (2019-2025) Figure Global Mild Cognitive Impairment Therapeutic Market Size Share by Regions in 2025 Figure North America Mild Cognitive Impairment Therapeutic Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Mild Cognitive Impairment Therapeutic Revenue (Million USD) and Growth Rate (2019-2025) Figure China Mild Cognitive Impairment Therapeutic Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Mild Cognitive Impairment Therapeutic Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Mild Cognitive Impairment Therapeutic Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Mild Cognitive Impairment Therapeutic Revenue (Million USD) and Growth Rate (2019-2025) Table Global Mild Cognitive Impairment Therapeutic Market Size by Application (2019-2025) (Million USD) Figure Global Mild Cognitive Impairment Therapeutic Market Size by Application (2019-2025) Figure Global Mild Cognitive Impairment Therapeutic Market Size by Application in 2025 Table Global Mild Cognitive Impairment Therapeutic Market Size by Type (2019-2025) (Million US$) Figure Global Mild Cognitive Impairment Therapeutic Market Size by Type (2019-2025) Figure Global Mild Cognitive Impairment Therapeutic Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Price : US$ 3500 | Date : Mar 2024 |
Category : Medical Devices | Pages : 233 |
Price : US$ 3500 | Date : Feb 2024 |
Category : Energy, Mining and Utilities | Pages : 142 |
Price : US$ 2450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 260 |
Price : US$ 2600 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 159 |
Price : US$ 2600 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 160 |
We will be happy to help you find what you need. Please call us or write to us: